首页> 外文期刊>The Journal of Organic Chemistry >Total syntheses of the histone deacetylase inhibitors largazole and 2-epi-largazole: Application of N-Heterocyclic carbene mediated acylations in complex molecule synthesis
【24h】

Total syntheses of the histone deacetylase inhibitors largazole and 2-epi-largazole: Application of N-Heterocyclic carbene mediated acylations in complex molecule synthesis

机译:组蛋白脱乙酰基酶抑制剂拉唑和2-表拉唑的总合成:N-杂环卡宾介导的酰化在复杂分子合成中的应用

获取原文
获取原文并翻译 | 示例
       

摘要

Details of the evolution of strategies toward convergent assembly of the histone deacetylase inhibiting natural product largazole exploiting γ,δ-unsaturated-α,β-epoxy-aldehydes and a thiazole-thiazoline containing ω-amino-acid are described. The initial N-heterocyclic carbene mediated redox amidation exploying these two types of building blocks representing largazole's structural domains of distinct biosynthetic origin directly afforded the seco-acid of largazole. This was accomplished without any protecting groups resident upon either thioester bearing epoxy-aldehyde or the tetrapeptide. However, the ineffective production of largazole via the final macrolactonization led to an alternative intramolecular esterification/macrolactamization strategy employing the established two building blocks. This provided largazole along with its C2-epimer via an unexpected inversion of the α-stereocenter at the valine residue. The biological evaluation demonstrated that both largazole and 2-epi-largazole led to dose-dependent increases of acetylation of histone H3, indicating their potencies as class I histone deacetylase selective inhibitiors. Enhanced p21 expression was also induced by largazole and its C2 epimer. In addition, 2-epi-largazole displayed more potent activity than largazole in cell viability assays against PC-3 and LNCaP prostate cancer cell lines.
机译:描述了利用γ,δ-不饱和-α,β-环氧-醛和噻唑-噻唑啉含有ω-氨基酸趋向组装抑制组蛋白脱乙酰基酶的天然产物largazole的策略的发展细节。最初的N-杂环卡宾介导的氧化还原酰胺化反应利用了这两种代表不同生物合成来源的拉格唑结构域的结构单元,直接提供了拉格唑的癸二酸。这是在没有任何保护基团驻留在带有环氧醛或四肽的硫酯上完成的。然而,通过最终的大环内酯化生产拉拉唑的效率低下,导致了采用已建立的两个构件的另一种分子内酯化/大分子内酰胺化策略。通过在缬氨酸残基处的α-立体中心的意外反转,提供了largazole及其C2-epimer。生物学评估表明,largazole和2-epi-largazole均导致组蛋白H3乙酰化的剂量依赖性增加,表明它们作为I类组蛋白脱乙酰基酶选择性抑制剂的潜能。拉拉唑及其C2差向异构体也诱导p21表达增强。另外,在针对PC-3和LNCaP前列腺癌细胞系的细胞活力测定中,2-表拉拉唑的活性比拉唑更强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号